DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,258,590 | +2.5% | 65,532 | -0.8% | 3.70% | +8.0% |
| Q2 2023 | $15,854,670 | -4.8% | 66,061 | -0.0% | 3.42% | -10.3% |
| Q1 2023 | $16,652,739 | -5.1% | 66,072 | -0.0% | 3.82% | -6.5% |
| Q4 2022 | $17,543,613 | +2.7% | 66,098 | -0.0% | 4.08% | -0.8% |
| Q3 2022 | $17,076,000 | +1.2% | 66,113 | -0.7% | 4.11% | +11.2% |
| Q2 2022 | $16,874,000 | -14.3% | 66,558 | -0.8% | 3.70% | -0.7% |
| Q1 2022 | $19,685,000 | -12.6% | 67,108 | -1.9% | 3.73% | -3.3% |
| Q4 2021 | $22,516,000 | +7.4% | 68,437 | -0.6% | 3.86% | -4.1% |
| Q3 2021 | $20,957,000 | +9.6% | 68,836 | -3.4% | 4.02% | +7.1% |
| Q2 2021 | $19,126,000 | +19.1% | 71,271 | -0.1% | 3.75% | +8.9% |
| Q1 2021 | $16,061,000 | +1.2% | 71,357 | -0.1% | 3.45% | -6.7% |
| Q4 2020 | $15,866,000 | +4.0% | 71,423 | +0.8% | 3.69% | -8.2% |
| Q3 2020 | $15,259,000 | +20.8% | 70,863 | -0.8% | 4.02% | +13.2% |
| Q2 2020 | $12,630,000 | +27.5% | 71,426 | -0.2% | 3.56% | +7.9% |
| Q1 2020 | $9,904,000 | -1.7% | 71,557 | +9.0% | 3.30% | +15.7% |
| Q4 2019 | $10,074,000 | +5.7% | 65,637 | -0.6% | 2.85% | -2.4% |
| Q3 2019 | $9,535,000 | +0.8% | 66,015 | -0.3% | 2.92% | -1.4% |
| Q2 2019 | $9,464,000 | +8.0% | 66,220 | -0.2% | 2.96% | +4.9% |
| Q1 2019 | $8,763,000 | +32.7% | 66,380 | +3.6% | 2.82% | +6.2% |
| Q4 2018 | $6,606,000 | -6.7% | 64,064 | -1.6% | 2.66% | +8.8% |
| Q3 2018 | $7,077,000 | +19.3% | 65,134 | +8.4% | 2.44% | +9.7% |
| Q2 2018 | $5,930,000 | +0.4% | 60,097 | -0.3% | 2.23% | -1.5% |
| Q1 2018 | $5,904,000 | +7.3% | 60,305 | +1.7% | 2.26% | +7.4% |
| Q4 2017 | $5,502,000 | +0.3% | 59,275 | -0.3% | 2.10% | -1.3% |
| Q3 2017 | $5,487,000 | +11.9% | 59,480 | +2.4% | 2.13% | +10.2% |
| Q2 2017 | $4,903,000 | -1.5% | 58,094 | -0.2% | 1.94% | -11.6% |
| Q1 2017 | $4,980,000 | +20.2% | 58,231 | +9.4% | 2.19% | +38.5% |
| Q4 2016 | $4,142,000 | +1.7% | 53,212 | +2.4% | 1.58% | -7.7% |
| Q3 2016 | $4,074,000 | +65.7% | 51,972 | +113.6% | 1.71% | +58.1% |
| Q2 2016 | $2,458,000 | +0.9% | 24,332 | -5.2% | 1.08% | +1.2% |
| Q1 2016 | $2,435,000 | +48.1% | 25,667 | +45.0% | 1.07% | +21.7% |
| Q4 2015 | $1,644,000 | – | 17,700 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |